+++ ₿₿ +++ Handeln Sie mit Kryptowährungen mit Hebel - Jetzt mehr erfahren!** +++ ₿₿ +++-w-
25.09.2021 18:48:33

Why Acceleron Pharma Stock Jumped This Week

Shares of Acceleron Pharma (NASDAQ: XLRN), a mid-cap hematology and pulmonary drugmaker, rose by a healthy 16.2% this week. While the catalyst behind this double-digit jump wasn't immediately apparent (the company didn't release any material news during the week), Bloomberg News reported late Friday afternoon that the company is in advanced talks to be acquired for approximately $11 billion, or $180 a share in an all-cash deal. Although Bloomberg couldn't identify the potential suitor in its initial report, Bristol Myers Squibb (NYSE: BMY) is the obvious candidate. Bristol already owns a sizable stake in Acceleron through its prior acquisition of Celgene, and the two companies are collaborating on the blood cancer drug Reblozyl and the late-stage pulmonary arterial hypertension (PAH) drug candidate Sotatercept.Image source: Getty Images.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu Acceleron Pharma Incmehr Analysen

Eintrag hinzufügen

Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!

Aktien in diesem Artikel

Acceleron Pharma Inc 147,00 -0,68% Acceleron Pharma Inc
pagehit